Short-read versus host-depleted nanopore mNGS on BALF (Hu et al. 2026)
Two clinical metagenomic workflows scored at organism level against culture, clinical microbiological tests and a composite reference standard.
Results are recorded on the linked protocols, tasks or configurations listed below. Their settings and evaluations are kept separate.
Overview
An explanatory profile has not yet been reviewed for this record.
Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.
Results on linked records
This benchmark has no results of its own in this release. 3 linked records have results. They are not assigned to the underlying benchmark: each record keeps its own settings and evaluations, and its scores are on its own page.
- Organism-level agreement with clinical microbiological tests (CMT), 62 BALF specimens (Hu et al. 2026) Protocol · part of this benchmark · 2 evaluations · 36 results
- Organism-level agreement with composite reference standard (CRS), 62 BALF specimens (Hu et al. 2026) Protocol · part of this benchmark · 2 evaluations · 36 results
- Organism-level agreement with routine culture, 62 BALF specimens (Hu et al. 2026) Protocol · part of this benchmark · 2 evaluations · 36 results
Methods and evaluation design
Procedure, tasks and evaluated configurations
Baseline coverage
Reference methods help show what a model adds beyond simple controls. We track a null control and a conventional method for each protocol.
0 of 6 active baseline roles have published Rewire measurements in this release. Measurements on a selected protocol do not establish coverage of an entire suite.
Baseline status by linked protocol
- Organism-level agreement with clinical microbiological tests (CMT), 62 BALF specimens (Hu et al. 2026) · 0/2 roles measured
- Organism-level agreement with composite reference standard (CRS), 62 BALF specimens (Hu et al. 2026) · 0/2 roles measured
- Organism-level agreement with routine culture, 62 BALF specimens (Hu et al. 2026) · 0/2 roles measured
Protocol coverage CSV (gzip) · Model evaluation matrix (gzip) · Source table (gzip) · Release and checksums (gzip)
Coverage is derived from release 2026-10-22-1b7cf027e4f6. Source citations describe the original records; they do not validate an unreviewed baseline proposal. No results have been generated by this audit.
Run instructions
No runnable recipe has been reviewed for this benchmark. Dataset access, model requirements, licences and compute requirements must be checked against its sources before execution.
Strengths, limitations and unresolved questions
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
0 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|
No evidence rows match these filters. Choose another scope or clear the search.
Sources and history
Release 2026-10-22-1b7cf027e4f6 · Record review: source checked
1 source record and release history
- Benchmarking next- versus third-generation sequencing in metagenomics: performance metrics and diagnostic efficacy · Original source · Microbiology Spectrum 14(7):e03993-25, published 2026-06-03; PMC13339908 full-text XML
Technical metadata and extraction receipts
Stable ID: dna-pathogen-20261011-hu2026-benchmark-ngs-tgs-balf
- areas
- microbes-communities
- contexts
- clinical_research
- entity level
- suite
- version
- Microbiology Spectrum 2026, Table 2 and Supplemental Tables S6 and S7
- task
- Detect organisms in a BALF specimen and agree with a reference standard
- source locator
- Methods 'Clinical performance evaluation and reference standards'; Results 'Diagnostic performance for clinical samples'
- scope note
- Mock-community results (Supplemental Tables S1 and S2, Figures 2 and 3) are per-organism rows and prose aggregates and were not extracted.
- limitations
- Organism-level agreement, not patient-level diagnosis.
Related records
- part of: Organism-level agreement with clinical microbiological tests (CMT), 62 BALF specimens (Hu et al. 2026)
- part of: Organism-level agreement with composite reference standard (CRS), 62 BALF specimens (Hu et al. 2026)
- part of: Organism-level agreement with routine culture, 62 BALF specimens (Hu et al. 2026)